secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2024-07-31T23:59:59+00:00
Accession:  0001932393-24-000043
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare reports Q2 2024: flat revenue, margin expansion, updates guidance
-------------------------------------------------------------------------------

- Revenue flat at $4.8B; organic revenue grew 1% YoY; net income margin improved to 8.9% from 8.7%.
- Adjusted EBIT margin expanded to 15.3% (up 60 bps); adjusted EPS rose to $1.00 from $0.92.
- Full-year organic revenue growth guidance lowered to 1-2% (from ~4%) due to China headwinds; adjusted EBIT margin guidance raised to 15.7-16.0%.
- Cash flow from operations was -$119M vs -$67M; free cash flow -$182M vs -$136M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000043/0001932393-24-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000043/gehc-20240731.htm
  HTML page:      https://secwatch.observer/filing/0001932393-24-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer